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Abstract:  Molecules of tris(2,2’-bipyridine-4-thiomethyl-BEDT-TTF)iron(II) (BEDT-
TTF = bis(ethylenedithio)tetrathiafulvalene)  assemble in pairs to form a novel 
supramolecular  capsular structure in the solid state. Three BEDT-TTF residues from one 
complex lie in the three grooves between coordinated bipyridines of the other complex, 
and vice versa, to form a capsule with three-fold rotational symmetry and an internal 
volume of ca. 160 Å3.  Further aspects of the coordination chemistry of this ligand, its 6-
substituted isomer and the 2,2’:6’2’’- terpyridyl-4’-thiomethyl-BEDT-TTF analogue are 
described. 
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Introduction. 
 
 
 
 
Scheme 1: Molecular structures of BEDT-TTF 1 and  TTF-, EDT-TTF and BEDT-TTF 
donors functionalized with metal binding groups 2-8.                    
 
 
BEDT-TTF 1 (Scheme 1) is a well-known organosulfur donor from which many 
radical cation salts and charge transfer compounds have been prepared.1  Its radical cation 
salts, prepared by electrocrystallisation or diffusion with an electron acceptor, exhibit a 
wide range of electrical properties including conductivity, semi-conductivity and the 
formation of low temperature superconductors such as (BEDT-TTF)2[Cu(NCS)2].
2  The 
salts have been intensively studied to gain a better understanding of their different 
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electrical properties and the mechanisms underlying changes in those properties on 
variation of temperature or pressure, as well as to explore properties such as 
ferroelectricity3 and thermopower.4  For any particular counterion there can exist 
different stoichiometries, polymorphs and solvates, with different electrical properties. 
For example, the  1:1 salt with triiodide has been exploited by combination with fullerene 
C60 to give a new conducting material,
5 while the β-2:1 salt has been incorporated in a 
pressure sensor6 and used for the production of superconducting nanoparticles.7  BEDT-
TTF is a component of several types of hybrid material such as paramagnetic 
superconductors prepared with iron(III) or ruthenium(III) tris-oxalates,8  and a material 
with coexisting conducting and ferromagnetic behavior composed of layers of BEDT-
TTF and mixed metal (Mn(II)/Cr(III)) honeycomb oxalate layers.9 BEDT-TTF has also 
formed salts with chiral anions, including induction of anion chirality through use of a 
chiral solvent.10 
 
 In the radical cation salts, the BEDT-TTF donors usually pack in layers, 
involving the formation of parallel stacks to give a two-dimensional conducting network 
via short S···S contacts, with different classes formed by variation in the orientation of 
the donors in the stack and between stacks as studied in detail by Mori.11  In contrast, 
layers composed of face-to-face pairs organized edge-to-face are observed in 
superconducting materials such as (BEDT-TTF)2[Cu(NCS)2] (Scheme 2).
2  Addition of 
large substituents to the BEDT-TTF moiety mitigate against such packings, leading to 
pairing of donors,  but two or more small substituents, e.g.  methyl or hydroxymethyl, are 
tolerated.12  It is of note that while the oxidized BEDT-TTF derivatives usually have a 
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planar organosulfur system, the neutral donors show more flexibility about the S···S 
vectors across the dithiole rings.13  
 
(a)                                                        (b) 
                           
Scheme 2.  Two examples of the donor packing arrangements within layers in the crystal 
structures of BEDT-TTF radical cation salts: (a) for (BEDT-TTF)2B5O6(OH)4, the β-type 
packing arrangement involves parallel stacks of tilted donors, (b) for (BEDT-
TTF)2.Cu(NCS)2 the κ-type packing involves perpendicular arrangements of pairs of 
face-to-face oriented donors.14 
 
Although a wide range of functionalized  BEDT-TTF derivatives, including chiral 
ones,  has been reported in recent years15 there is only one molecule reported, 2, which 
contains more than one BEDT-TTF moiety.16 Attachment of several BEDT-TTFs 
together   has the potential to apply a constraint to the organization of the molecules in 
the solid state and lead to new crystal packing arrangements, and thus new physical 
properties, for their radical cation salts. One way of achieving this is to functionalize 
BEDT-TTF with a group capable of binding to a metal ion and then form bis or tris 
complexes around the metal, and finally oxidize such materials to their radical cation 
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salts.    Herein we report the production of a completely novel capsular motif by the tris 
iron(II) complex of  BEDT-TTF functionalized with a 2,2’-bipyridine-4-thiomethyl 
group, L2, a ligand whose synthesis we have reported along with those of two other 
BEDT-TTFs: the 6-thiomethyl isomer L1 and the 2,2’:6’2”-terpyridyl derivative L3 
(Scheme 3).17 Other aspects of the coordination chemistry of this family of ligands are 
also reported. Other groups have attached metal binding groups to organosulfur donor 
molecules: a number of examples have involved pyridines or, in just a few cases, a  2,2’-
bipyridine or a 2,2’:6’,2”-terpyridine as in 3-5,18 as well as phosphines19 and their 
combination with other metal binding groups  as in 6,20 and the use of 2,2’-bipyridines as  
linkers between TTFs21 and between TTF  and a verdazyl radical as in 7 and 8 (Scheme 
2).22    Lorcy et al. have extensively reviewed these types of material and their 
coordination chemistries.23  
 
 
 
Scheme 3.  Molecular structures of novel donors L1, L2 and L3. 
 
Discussion. 
Tris complexes of ligand L2 with first row divalent transition metal cations  (Mn, Fe, 
Co, Ni, Cu, Zn) were prepared as their PF6 salts in 61-95% yields by refluxing a 
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dichloromethane solution of three equivalents of the ligand L2 with a methanolic solution 
of the metal acetate, and precipitating the product by addition of ammonium 
hexafluorophosphate. Compositions were supported by microanalyses and observations 
of [M-PF6]
+ and/or [M-2PF6]
2+ ions in the electrospray mass spectra.  After many 
attempts with these materials, solvated crystals of the tris complex with iron(II), 
[Fe(L2)3](PF6)2, were obtained by slow diffusion of methanol into a nitrobenzene 
solution, and their composition studied by single crystal X-ray diffraction. The crystal 
structure is quite remarkable; fac-complexes have crystallized together in pairs to form a 
capsule motif (Fig. 1).  The unsubstituted “ends” of three electron-rich BEDT-TTF 
groups of one [Fe(L2)3]
2+ complex lie in the three grooves between the bipyridine groups 
around the iron cation of the other [Fe(L2)3]
2+ complex and vice versa. The resultant 
interlocking of BEDT-TTF units and tris(bipyridyl)Fe(II) groups produces a “molecular 
container” with internal volume of approximately 160  Å3. This is a totally new packing 
behavior for the BEDT-TTF molecule.   
 
Crystals of solvated [Fe(L2)3](PF6)2 are rhombohedral, space group R-3, with three 
capsule cations comprising six metals and eighteen ligands per unit cell, with the cation 
exhibiting crystallographic three-fold rotational symmetry with the rotation axis passing 
through the two iron centers generating a 50:50 mixture of  and  forms related via a 
crystallographic inversion centre.  Difference electron density maps indicate there is 
some electron density inside the capsule.  However, there is also a very considerable 
amount of space between the capsules in the crystal structure, comprising ca. 40% of the 
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unit cell volume, which is occupied by counterions (up to four per capsule) and solvents 
in a disordered way,  for which no convincing structural model could be established. The  
                                    
 
                                     
Figure 1.  View of the [Fe(L2)3]
2+ complex with the three BEDT-TTF moieties directed  
forward (above), and view of the  capsule ([Fe(L2)3]2)
4+
 down the three fold rotation axis, 
showing how the three BEDT-TTF groupings from one complex lie between the 
bipyridyl groups of the other. 
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Figure 2. Space-filling view of the capsule with one ligand of L2 shown in ball-and-stick 
mode to give a view of the inside of the capsule and of how the ligand coordinates to one 
Fe(II) and then positions its BEDT-TTF fragment between two bipyridyl groups at the 
second Fe(II) center. 
  
PLATON/SQUEEZE24 procedure was thus applied to the diffraction data, to exclude the 
solvent and the anions from the model. The results suggest > 3000 electrons per unit cell 
in the inter-capsular space, and ca. 56 electrons inside the capsule. We thus propose that 
the capsules are probably occupied by solvent (methanol) or in some cases by a 
PF6¯anion (69 electrons). However, the limitations of the structural model do not justify a 
more detailed discussion of the contents.  Nevertheless, despite the significant solvent 
and anion disorder, the cation geometry is well-defined.           
                                    
The internal dimensions of the cavity of the capsule are ca. 6Å along the three-fold 
axis and ca. 7Å in directions perpendicular to this, corresponding to a volume ca. 160     
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Å 3.  The PF6─ anion has a volume of ca. 105 Å
3 and could feasibly be enclosed in a 
fraction of the capsules.   The walls of the cavity are formed by the organosulfur portions 
of the substituted  1,3-dithiolo-1,4-dithiin units of six BEDT-TTF groups, and the capsule 
is closed top and bottom by the undersides of two tris(bipyridyl)Fe(II) units and their      
–SCH2– linkages to the BEDT-TTF units (Fig. 2). The rest of the organosulfur residue of 
each BEDT-TTF wraps around the outside of the bipyridines. The structure 
accommodates both enantiomers of the racemic ligand L2 which contains a stereogenic 
centre at the point of attachment of the side chain to the BEDT-TTF moiety.  For the two 
enantiomeric forms, the locations of the bipyridine and most of the BEDT-TTF group are 
coincident, which is achieved by modifying the conformation of the dithiin  ring  so  that   
 
 
Figure 3.  View showing how the two enantiomers of L2 are modeled, with the different 
positions for just the substituted ethylene bridge, side chain methylene group and one 
sulfur atom. Hydrogen atoms and a pyridine ring are omitted for clarity. 
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the –CH2S– side chain can take a pseudo-equatorial orientation for one enantiomer and a 
pseudo-axial orientation for the other enantiomer and so maintain very similar relative 
orientations of the BEDT-TTF and bipyridine units  (Fig. 3).  For a centrosymmetrically 
related ligand (space group R-3), there will be an opposite assignment of chirality to the 
pseudo-equatorial and pseudo-axial conformations. 
 
 The BEDT-TTF groups forming the capsule walls are slightly curved, with the 
central S2C=CS2 fragment of the TTF ring very nearly planar but with flexings of 14.9
o 
and 20.2o about the S···S vectors across the two dithiole rings, so that the dithiin sulfur 
atoms are displaced inwards from the central S2C=CS2 plane by 0.717–1.134 Å. The 
capsule formation is stabilized by interactions between the electron-deficient pyridine 
rings and the electron-rich BEDT-TTF groups belonging to the opposite iron complex. 
The unsubstituted “half” of each organosulfur donor lies in the cleft between two 
bipyridine rings making contact with one bipyridine system “face to face”, and directing 
its edge to the face of the second bipyridine ring (Fig. 2). One dithiole S atom, S4, is 
central to both interactions (Fig. 4).  For the face-to-face interaction, this dithiole S atom 
lies over the center of the substituted pyridine ring at a perpendicular separation of  3.537 
Å from its best plane, with shortest C···C contacts between the dithiole and pyridine 
rings of 3.429  and 3.512 Å.  The terminal dithiin S atom, S2, lies over the space between 
the 3-H and 3’-H atoms of the bipyridine system (S···H 3.48 and 3.55 Å).  The other S 
atom in the dithiole ring, S3, makes a S···S contact of 3.780 Å with the side-chain S atom 
connected to the pyridine ring.  The edge of the donor makes shorter contacts to the face 
of the second bipyridine ring. Thus, dithiole sulfur atom S4 lies over the unsubstituted 
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pyridine ring at 3.312 Å above the best plane through the ring, with two particularly short 
S···C contacts of  3.436 and 3.437 Å, respectively, to the 5- and 6-C atoms of that 
pyridine ring. The observation of shorter S···C contacts from the edge of the donor rather 
than from its face  is in accord with the asymmetric shape of the bonded divalent sulfur 
atom.25 The edge-to-face contact is completed by sulfur atoms from the next dithiole and 
dithiin rings, S6 and S8, which lie 3.441 and 3.327 Å, respectively, from the bipyridine 
plane, but the former is oriented over the space between the two 3- and 3’- hydrogen 
atoms (S···H 3.66 and 3.70 Å) and the latter lies close to the bond from the pyridine ring 
to the side chain S atom (S···C 3.624, S···S 3.706 Å).  The Fe─N distances of 1.955(3) 
and 1.971(3) Å are typical for a low spin Fe(II) tris(bipy) complex (1.96 ± 0.04 Å).26   
 
 
Figure 4.  Disposition of one BEDT-TTF residue in the cleft between two bipyridine 
rings in ([Fe(L2)3])2
4+. BEDT-TTF residues are omitted from the bipyridines and vice-
versa for clarity. 
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  There are no particularly short S···S contacts between donor moieties within the 
capsule, the shortest being 3.706(3) Å between a dithiin S atom and the side chain S of 
another BEDT-TTF unit.  The shortest inter-capsule S···S contacts involve dithiole S 
atoms, and the three shortest lie in the range 3.594–3.648 Å.   
 
 Cyclic voltammetry of this series of complexes shows very similar oxidation 
potentials to BEDT-TTF with first and second oxidations typically at 0.56 and 0.88 V 
relative to Ag/AgCl (Table S1).  Room temperature magnetic moments were also 
recorded (Table S2), and are consistent with those of tris(2,2’-bipyridyl) complexes.27 Fe 
tris-bipyridine and its derivatives are well known to adopt low spin (S = 0) configurations 
with the high spin configuration only accessible as a short-lived excited state identified 
by femtosecond spectroscopy.26  Variable temperature magnetic studies on 
[Fe(L2)3](PF6)2 revealed a weak Curie tail corresponding to trace paramagnetic impurity 
(ca. 1.2% S = 2 high spin FeII or 0.8% S = 5/2 FeIII) coupled with a component arising 
from temperature independent paramagnetism (TIP). The exact value of the TIP term is 
difficult to determine due to uncertainty in the diamagnetic correction (residual lattice 
solvent, gelatin capsule etc.) but is of the order of 10-3 emu·mol-1. 
 
 Although there is an extensive literature on the formation of molecular capsules,28 to 
our knowledge none have been reported where the walls are formed mainly by 
organosulfur donors.  Nevertheless, TTF-related species have found application in the 
preparation of cavitands, carcerands and also as functionalities for calixarene based 
sensors29 and supramolecular applications of TTF have been reviewed.30 
13 
 
 
Further coordination chemistry of ligand L2. 
Ligand L2 shows further coordination chemistry, for example forming 1:1 complexes 
with M(hfac)2 (M = Mn, Co, Ni, Cu, Zn)
31 to give six-coordinate [(L2)M(hfac)2] 
complexes in  70-80 % yield, and with Nd(hfac)3 to give the eight-coordinate 1:1 
complex  [(L2)Nd(hfac)3] in 80% yield. The formulations of the complexes are supported 
by chemical analyses, and their mass spectra typically show peaks at m/z: [M - hfac]+. 
The [(L2)M(hfac)2] complexes showed very similar cyclic voltammetry data to BEDT-
TTF (Table S1), suggesting that coordination is taking place only at the N atoms, and that 
the materials are simple octahedral complexes with one bipyridine and two hfac ligands 
(Scheme 4). The magnetic moment of the complex with Co(II) is consistent with the 
lower ligand field strength of a [M(bipy)(hfac)2] complex compared to that in the tris(L2) 
complex (Table S2). Ligand L2 also formed (L2)2MnCl2, a 2:1 complex with MnCl2, 
which is assigned as the cis complex by analogy with similar cases,32 and also L2CuCl2, a 
1:1 complex with CuCl2. 
 
 
           
Scheme 4:  [(L2)M(hfac)2] complexes with divalent transition metal ions and the 
[(L2)M(hfac)3] complex with Nd(III). 
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Chemistry and crystal structure of 6-substituted bipyridyl ligand L1. 
 
 
 
 
 
     
Figure 5. The molecular and crystal structures of ligand L1 showing the weak 1,5 N···H 
interaction (left) and the segregation of BEDT-TTF and bipyridine units (right).   
 
In contrast to L2, it was not possible to isolate any stable complexes containing 
ligand L1, in which the BEDT-TTF-CH2-S- side chain is attached to the 6-position of the 
bipyridine, in conditions which were successful for ligand L2. 6-Substitution does not 
necessarily prevent a bipyridine from coordinating.33 In the crystal structure of ligand  L1 
(Fig. 5) the side chain lies in a pseudo-equatorial position from the dithiin ring which 
adopts an approximate boat type conformation. The –S-CH2– group takes an extended 
conformation and links to the trans-bipyridine system so that the S-CH2 bond lies 
roughly syn to the adjacent CN bond of the pyridine ring. This leads to a short (1,5) 
N···H contact of 2.37 Å between the ring N atom and the side chain methylene group; 
this weak hydrogen bond will be enhanced by electron donation from the side chain 
sulfur atom to the ring nitrogen atom. The pyridine and organosulfur residues are more or 
less segregated in the crystal structure. The lack of stability of complexes of L1 may be 
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due to a number of factors including the bulk of the BEDT-TTF group and the weak 
intramolecular interaction discussed above. Furthermore, there may be a kinetic factor,  
since these large organosulfur units may aggregate in solution and shield the pyridine 
nitrogen atom from potential coordination sites. Unusual and unexpected chemistry has 
been observed before with the BEDT-TTF system.17,34   
 
Coordination chemistry of terpyridyl ligand L3 . 
  
As a comparison to L2, the coordination chemistry of ligand L3, which carries a 
terpyridyl ligand, with first row transition metals has also been investigated.  Bis 
complexes of ligand L3 with M(II) (M = Mn, Fe, Co, Ni, Cu, Zn) were prepared in 57-
82% yields by refluxing  a dichloromethane solution of two equivalents of the ligand with 
a methanolic solution of the metal acetate, followed by precipitation of the product with 
ammonium hexafluorophosphate. Compositions were supported by microanalyses, but 
we were unable to grow suitable crystals for structural characterization, possibly due to 
the presence of two diastereomers.  It would be expected that the two terpyridyl groups 
would be roughly perpendicular to each other (Scheme 5).  The cyclic voltammetry of 
these complexes shows that first oxidation potentials are ca. 0.03 V higher and the second 
oxidation potentials are ca. 0.08 V lower than those for BEDT-TTF  (Table S1).  The 
room temperature magnetic moments of the complexes are consistent with the higher 
ligand field of bis(terpy) complexes (Table S2).35 The magnetic measurement of the  
Fe(II) complex showed similar behavior to the tris-L2 derivative, i.e comprising a small 
concentration of a paramagnetic defect (0.6% high spin FeII) and a temperature 
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independent paramagnetism term of a comparable magnitude to that observed for the 
tris(L2)Fe(II) complex.  
  
 
Scheme 5:  Bis-complexes of ligand L3 with divalent transition metal ions. 
 
Conclusion. 
 
 We have demonstrated that ligand L2 is capable of forming a molecular capsule 
with Fe(II) when the counterion is PF6
¯. Two tris complexes of formula [Fe(L2)3]
2+ 
combine together with the three electron-rich organosulfur donors of one complex lying 
in the electron deficient grooves between the bipyridine groups of the other to form the 
capsule, and vice versa. The encapsulated volume could accommodate a PF6
¯ ion but this 
could not unambiguously be confirmed from the X-ray structure determination. The 
capsular framework structure can accommodate either enantiomer of ligand L2 at each 
site, by adjusting the conformation of the substituted dithiin ring, so that the side chain 
lies either pseudo–equatorial of pseudo-axial. The corresponding complexes with first 
row divalent metal ions Mn(II) and Co(II)-Zn(II) were prepared and may also possess 
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analogous structures, but we were unable to obtain crystals suitable for measurement. The 
oxidation potentials of the ligand are not affected by formation of these structures.  
Ligand L2 behaves as a typical 4-substituted bipy ligand, forming complexes of type    
[(L2)M(hfac)2] (M = Mn(II), Co(II)-Zn(II)) and [(L2)2MnCl2], while its 6-substituted 
isomer did not form any complexes at all with divalent first row transition metal ions. 
The corresponding 4’-substituted terpy ligand formed bis complexes of type 
[(L3)2M](PF6)2 (M = Mn(II)-Zn(II))  in which the ligand had a slightly higher first 
oxidation potential than BEDT-TTF.   
 
The novel capsular structure of the complex [(L2)3Fe(II)]2
4+ opens up the 
possibility of new applications of the structurally flexible BEDT-TTF unit.  Extension of 
the chains linking the bipyridine ring and BEDT-TTF group, for example by including 
aromatic rings, offers the opportunity to encapsulate larger species e.g. fullerenes. Tris-
(BEDT-TTF)-functionalization of a template which did not stabilize capsule formation 
could lead to a species capable of accepting large electron-deficient species. Furthermore, 
the opportunity to address the BEDT-TTF units electrochemically offers the chance to 
bind or release such species.  The preparation of charge transfer salts of the complexes 
described herein is in progress.  
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Experimental. 
 
General. NMR spectra were measured on a JEOL ECLIPSE 400 spectrometer at 400 
MHz for 1H and at 100 MHz for 13C{1H} using CDCl3 as solvent and tetramethylsilane 
(TMS) as standard unless otherwise stated, and measured in p.p.m. downfield from TMS 
with coupling constants reported in Hz. IR spectra were recorded on a Perkin Elmer 
Spectrum 100 FT-IR Spectrometer as KBr disks and are reported in cm-1. Mass spectra 
were recorded at the EPSRC Mass Spectrometry Centre at the University of Swansea. 
Chemical analysis data were obtained from Mr Stephen Boyer, London Metropolitan 
University.  Flash chromatography was performed on 40-63 silica gel (Merck). Ligands 
L1-L3 were prepared according to the procedures previously reported.17 Cyclic 
voltammetry measurements were made using an μAutolab type II from Metrohm Autolab 
B.V. Magnetic susceptibility measurements were performed with a  Quantum Design 
MPSM2 SQUID magnetometer using randomly oriented polycrystalline material encased 
in aluminium foil at 0.1 Tesla. 
 
 
Preparation of [M(L2)3](PF6)2. 
[Zn(L2)3](PF6)2. A solution of zinc acetate (0.010 g, 0.046 mmol) in MeOH (2 mL) was 
added to a solution of ligand L2 (0.081 g, 0.14 mmol) in CH2Cl2 (7 mL) and the mixture  
refluxed for 2 h. After stirring at room temperature overnight, addition of NH4PF6 (0.031 
g, 0.19 mmol) in MeOH (3 mL) gave instant formation of yellow precipitate which was 
stirred for a further 1 h. The yellow solid was collected by filtration, washed with MeOH 
and then CH2Cl2 and dried under vacuum. Yield 0.070 g (72%).  Calc. for 
C63H48F12N6P2S27Zn·H2O, C 35.55, H 2.37, N 3.95%, found C 35.40, H 2.28, N 3.64%; 
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m/z (ES) 1965 [MPF6], 910 [M2 PF6]2; max (KBr): 1592, 1571, 1437, 1408, 1016, 
842, 788,  558 cm1; 1H NMR (DMSO-d6):  = 7.35-8.90 (br, m, 21H, Ar-H21), 4.12 (br, 
3H, SCHCH2), 3.25-3.95 (m, 24H, 12 xCH2); 
31P{1H}  NMR (DMSO-d6):  =  –142.84 
(septet, JF-P = 711 Hz, PF6).  The product was insoluble in normal organic solvents 
except DMSO. The following complexes were prepared following the same general 
procedure: 
 [Mn(L2)3](PF6)2: yellow solid, yield 61%; Calc. for C63H48F12MnN6P2S27, C 36.04, H 
2.30, N 4.00%, found C 35.79, H 2.27, N 3.77%; m/z (ES) 1955 [MPF6], 904 [M2 
PF6]
2; max (KBr): 1590, 1570, 1436, 1407, 843, 789, 558 cm1. 
[Fe(L2)3](PF6)2: from iron(II) chloride, purple solid, yield 70%; Calc. for 
C63H48F12FeN6P2S27, C 36.02, H 2.30, N 4.00%, found C 35.69, H 2.33, N 3.68%; m/z 
(ES) 904.9 [M2 PF6]2; max (KBr): 1597, 1466, 1437, 1407, 843, 784, 558 cm1.    
[Co(L2)3](PF6)2: brown-yellow solid, yield 95%; Calc. for C63H48CoF12N6P2S27, C 35.97, 
H 2.30, N 3.99%, found C 36.37, H 2.23, N 3.89%; m/z (ES) 1959 [MPF6], 907 [M2 
PF6]
2; max (KBr): 1592, 1570, 1534, 1472, 1437, 1409, 842, 788, 773, 558  cm1. 
[Ni(L2)3](PF6)2: brown-yellow solid, yield 76%; Calc. for C63H48F12N6NiP2S27.H2O, C 
35.67, H 2.38, N 3.96%, found C 35.36, H 2.21, N 3.67%; m/z (ES) 1959 [MPF6], 907 
[M2 PF6]2; max (KBr): 1593, 1570, 1438, 1406, 842, 788, 558 cm1. 
[Cu(L2)3](PF6)2: light-brown solid, yield 79%; Calc. for C63H48CuF12N6P2S27, C 35.89, H 
2.29, N 3.99%, found C35.66, H 2.28, N 3.71%; m/z (ES) 1962 [MPF6]; max (KBr): 
1595, 1570, 1438, 1406, 843, 788, 558 cm1. 
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Synthesis of [(L2)M(hfac)2] complexes. 
[(L2)Zn(hfac)2] A solution of  L2 (0.074 g, 0.13 mmol) in dry CH2Cl2 (10 mL) was 
added to a solution of Zn(hfac)22H2O (0.065g, 0.13 mmol) in dry acetone (3 mL) and the 
solution was heated to reflux for 1 h under nitrogen followed by stirring for 20 h. at RT. 
Removal of solvents gave an orange solid which was extracted with Et2O. Removal of 
Et2O from the filtrate afforded an orange solid which was recrystallized from CH2Cl2/n-
hexane to give [Zn(L2)(hfac)2] as an orange powder (yield 0.12 g, 85%). Calc. for 
C31H18N2O4F12S9Zn: C 34.98, H 1.70, N 2.63%; found C 35.21, H 1.78, N 2.43%; max  
(KBr): 1648, 1607, 1594, 1554, 1528, 1499, 1474, 1257, 1202, 1145, 1093, 792, 666, 
584, 527 cm1; 1H NMR (CDCl3):  = 8.68 (1H, br d, 4.4 Hz, 6’’’-H);  8.48 (1H, d, 5.7 
Hz, 6’’-H),  8.17 (1H, br d, J = 8.0 Hz, 3”’-H), 8.11 (1H, dt, J = 7.6, 1.6  Hz, 4”’-H), 8.00 
(1H, d, J = 1.6 Hz, 3’’-H), 7.66 (1H,  br t, J = 6.2 Hz, 5’’’-H ), 7.42 (1H, dd, 5.6, 1.6 Hz, 
5’’-H), 5.98 (2H, s, hfac), 3.81-3.87 (1H, m, 5-H), 3.62 (1H, dd, J = 14.2, 5.8 Hz, 
5CHαS), 3.53 (1H, dd, J = 14.2, 8.8 Hz, 5-CHβS), 3.42 (1H, dd, J = 13.6, 2.8 Hz, 6-Hα),  
3.35 (1H, dd, J = 13.6, 4.4 Hz, 6-Hβ), 3.28 (4H, s, 5’-,6-H2); 13C{1H}  NMR (CDCl3):  = 
178.7 (q, JC,F = 33 Hz , hfac  4 x C=O), 154.0 (2’-,2’’-C), 149.4 & 148.4 (6’-,6’’-C), 
148.2 (4’-C), 140.3 (4’’-C), 126.9 (5’’-C), 122.5 (3’’-C), 121.1 (5’-C), 117.8 (3’-C), 
117.4 (q,  JC,F = 284 Hz, hfac, 4 xCF3), 114.0, 113.7, 113.1, 112.5, 112.1 (6 x SCS),  89.0 
(hfac, 2 x CH), 41.0 (5-C), 34.9 & 33.3 (5-CH2, 6-C) x SCH2), 30.1 (5’-,6’-C);  m/z  
(ES+): 855, 857, 859 [M-hfac]+. 
 
 
 
21 
 
A series of further complexes were prepared by the same method in 70-80% yield. 
[(L2)Mn(hfac)2]   
Calc. for C31H18N2O4F12S9Mn: C 35.33, H 1.72, N 2.66%; found C 35.62, H 1.67, N 
2.49%; max (KBr):  1647, 1591, 1528, 1498, 1474, 1256, 1203, 1146, 793, 664,  584 
cm1; m/z  (ES+): 846 [M-hfac]+.    
[(L2)Co(hfac)2] 
Calc. for C31H18N2O4F12S9Co: C 35.19, H 1.71, N 2.65%; found C 35.56, H 1.71, N 
2.45%; max (KBr):  1641, 1594, 1528, 1474, 1257, 1203, 1146, 793, 668,  585 cm1;  m/z  
(ES+): 850 [M-hfac]+.    
[(L2)Ni(hfac)2] 
Calc. for C31H18N2O4F12S9Ni: C 35.20, H 1.72, N 2.65%; found C 35.40, H 1.69, N 
2.39%; max (KBr):  1645, 1595, 1524, 1500, 1498, 1474, 1257, 1203, 1147, 792, 671,  
587 cm1;  m/z  (ES+): 849, 851 [M-hfac]+.    
[(L2)Cu(hfac)2] 
Calc. for C31H18N2O4F12S9Cu: C 35.04, H 1.71, N 2.64%, found C 35.33, H 1.70, N 
2.49%; max (KBr):  1670,  1662, 1654, 1650, 1598, 1550, 1528, 1491, 1258, 1203, 1147, 
793, 667,  586 cm1 ;  m/z  (ES+): 854, 856 [M-hfac]+.    
 
Preparation of [(L2)Nd(hfac)3] 
A solution of   L2 (0.025g, 0.043 mmol) in dry CH2Cl2 (7 mL) was added to a solution of 
Nd(hfac)3.2H2O (0.034 g, 0.042 mmol) dissolved in dry acetone (1.5 mL). The orange 
solution was heated to reflux for 3 h under nitrogen followed by stirring for 16 h at RT. 
Removal of solvents gave an orange solid which was extracted into a small amount of 
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DCM, n-hexane was layered onto the DCM solution and stored overnight at 0oC. The 
orange precipitate was collected by filtration washed with n-hexane and dried. Yield 
0.046 g, (80%). Calc. for C36H19F18N2NdO6S9:  C 32.02, H 1.42, N 2.07%, found C 
31.88, H 1.34, N 2.10%; max (KBr): 1720, 1696, 1650, 1592, 1572, 1534, 1475, 1437, 
1257, 1204, 1147, 1013, 797, 720, 660, 585 cm1.  The solid was insoluble in MeOH, 
Et2O, CH3CN, soluble in acetone (but slowly decomposes), and less soluble in DCM and 
CHCl3. 
 
 
Preparation of [M(L3)2](PF6)2. 
[Zn(L3)2](PF6)2: A solution of Zn(OAc)2 (0.013 g, 0.056 mmol) in MeOH (2 mL) was 
added to a solution of ligand  L3 (0.075 g, 0.12 mmol) in CH2Cl2 (7 mL) and the solution 
was refluxed for 2 h. After stirring at room temperature overnight, a solution of NH4PF6 
(0.037 g, 0.22 mmol) in MeOH (3 mL) gave instant formation of a yellow precipitate 
which  was stirred for a further 1 h. The yellow solid was collected by filtration, washed 
with MeOH and then CH2Cl2 and dried under vacuum. Yield 0.070 g (75%). Calc. for 
C52H38F12N6P2S18Zn: C 37.19, H 2.28, N 5.00%, found C 37.18, H 2.12, N 4.75%; . m/z 
(ES) 1534 [M PF6], 695 [M2PF6]2; max (KBr): 1593, 1570, 1544, 1475, 1420, 1016, 
841, 788,  558  cm1; 1H NMR (CD3CN):  = 8.54 (s,  4H, 2 x 3’-,5’-H), 8.39 (d, 4H, J = 
8.0 Hz, major) & 8.43 (d, 4H, J = 8.0 Hz, minor) (2 x 3-,3’’-H), 8.08-8.13 (m, 4H, 2 x 4-
,4’’-H), 7.80 (d, 4H, J = 4.4 Hz, 2 x 6-,6’’-H), 7.31-7.37 (m, 4H, 2 x 5-,5’’-H), 4.31-4.38 
(m), 4.20-4.28 (m), 3.62-3.73 (m), 3.48-3.52 (m), 3.12-3.31 (m) (SCH & 4 x SCH2, major 
and minor diastereomers); 13C{1H} NMR (CD3CN): major diastereomer  =  161.1, 
149.4, 148.9, 148.2,  141.6, 128.5, 123.6, 120.3 (2 x Ar-C8),  114.0,  113.6, 112.1, 110.6, 
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109.2, 109.1 (6 x sp2C, BEDT-TTF), 44.4 (SCH), 35.4 (SCH2), 33.9 (SCH2), 30.6 
(SCH2CH2S); minor diastereomer  =  160.8, 149.4, 148.9, 148.2,  141.7, 128.5, 123.7, 
120.4 (2 x Ar-C8),  114.1,  113.8, 112.5, 111.6, 109.8, 109.6 (6 x sp
2C, BEDT-TTF), 44.1 
(SCH), 35.7 (SCH2), 34.1 (SCH2), 30.7 (SCH2CH2S); 
31P{1H} NMR (CD3CN):   = –
143.17 (septet, JF-P = 707 Hz, PF6). 
 
The following complexes were prepared following the same general procedure: 
[Mn(L3)2](PF6)2: yellow solid, yield 63%; Calc. for C52H38F12MnN6P2S18·2.5H2O, C 
36.44, H 2.53, N 4.90%, found C 36.21, H 2.26, N 4.73%. m/z (ES) 691 [M2PF6]2; 
max (KBr)   1591, 1570, 1541, 1476, 1418, 1014, 840, 788, 558  cm1. 
 [Fe(L3)2](PF6)2: from iron(II) chloride, purple solid, yield 82%; Calc. for 
C52H38F12FeN6P2S18: C 37.40, H 2.29, N 5.03%, found C 37.38, H 2.40, N 4.97%; m/z 
(ES) 1525 [M PF6]; max (KBr):  1600, 1560, 1533, 1466, 1424, 1397, 1122, 1108,  
840, 785, 558  cm1.  
[Co(L3)2](PF6)2: light brown solid, yield 73%; Calc. for C52H38CoF12N6P2S18.H2O: C 
36.94, H 2.38, N 4.97%, found C 36.76, H 2.19, N 4.83%; m/z (ES) 1526 [MPF6], 690 
[M2PF6]2; max (KBr): 1596, 1569, 1542, 1473, 1420, 1121, 1017, 841, 787, 558  cm1. 
[Ni(L3)2](PF6)2: orange-yellow solid, yield 57%; Calc. for C52H38F12N6NiP2S18.H2O: C 
36.94, H 2.38, N 4.97%, found C 36.86, H 2.20, N 4.73%; m/z (ES) 1525 [MPF6], 690 
[M2PF6]2 ; max (KBr): 1595, 1570, 1543, 1474, 1420, 1016, 842, 788, 558  cm1.  
[Cu(L3)2](PF6)2: light-brown solid, yield 63%; Calc. for C52H38CuF12N6P2S18·H2O: C 
36.83, H 2.38, N 4.96%, found C 36.63, H 2.24, N 4.71%; m/z (ES) 1532 [MPF6], 693 
[M2PF6]2; max (KBr): 1595, 1571, 1542, 1474, 1420, 1020, 841, 788, 558  cm1.  
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 Preparation of complexes of ligands L2 with MnCl2 and CuCl2. 
 
[(L2)CuCl2]: A solution of CuCl22H2O (11 mg, 0.068 mmol) in dry MeOH (3 mL) was 
added to a solution of  L2 (40.0 mg, 0.068 mmol) in dry DCM (10 mL) to give  slow 
formation of a brown precipitate. The mixture was stirred in the dark under a N2 
atmosphere for 20 h. The precipitate was collected by filtration, washed with MeOH and 
then DCM, and dried under vacuo to give the product  as a brown powder,   (0.03g, 
61.4%). Calc. for C21H16N2S9CuCl2: C 35.06, H 2.24, N 3.89%; found C 35.24, H 2.14, N 
3.69%; m/z (ES): 684 [M Cl], 584 [M  CuCl2]; max (KBr): 2915, 1594, 1569, 1534, 
1467, 1437, 1404, 1317, 1284, 1166, 1115, 1052, 1026, 1012, 886, 818, 788, 772, 718, 
597 cm1. The solid was insoluble in common organic solvents but reasonably soluble in 
DMSO and DMF. 
 
[Mn(L2)2Cl2]: A solution of MnCl24H2O (24.0 mg, 0.12 mmol) in MeOH (2 mL) was 
added to a CH2Cl2 (15 mL) solution containing L2 (0.15 g, 0.25 mmol) to give an 
immediate orange precipitate. The mixture was stirred at RT for 2 h and the solid 
collected by filtration followed by washing with MeOH and then CH2Cl2 and dried under 
vacuum to give [(L2)2MnCl2]. Yield 0.13 g, (80%). Calc. for C42H32Cl2MnN4S18: C 
38.93, H 2.49, N 4.32%, found C 38.49, H 2.49, N 4.10%;  m/z (ES) 585 [L2 + H]; max 
(KBr): 2916, 1590, 1571, 1534, 1473, 1405 ( br), 1314, 1285, 1259, 1118, 1052, 1012 , 
818, 790, 771, 714, 601  cm1.  
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X-Ray Crystallography. 
 
 
 [(L2)3Fe(II)]24PF6.(C6H5NO2)x.(CH3OH)y:  Diffraction-quality single crystals were 
obtained from nitrobenzene/methanol. The structure was solved using SHELXS9736 and 
refined using SHELXL97.36 The crystal contained large voids occupied by disordered 
solvent molecules (methanol and nitrobenzene) and PF6
– anions which could not be 
resolved, so the structure of the cation was refined after application of the SQUEEZE24 
program to exclude anions and solvents from the model. Both enantiomers of  ligand L2 
are included in the model, with identical positions for all atoms except those of the 
substituted ethylene bridge, the side chain methylene carbon and the dithiin sulfur nearest 
to the substitution position. The unsubstituted ethylene bridge is disordered between two 
conformations.  
Crystal data:  C63H48N6S27Fe.(PF6)2, Mr = 2100.48, trigonal, a = b = 23.8874(12), c = 
36.086(4) Å, V = 17832(2)  Å3, Z = 6, R-3,  (Mo-K) =  0.68  mm-1, T =  120  K,    6963  
unique reflections,  3760  with Fo > 4(Fo), final R1 = 0.054; wR2 = 0.14, crystals from 
nitrobenzene/methanol. Illustrations were  prepared using Mercury,37 ORTEP-3 for 
Windows38 and POV-RAY.39  
 
Crystal data for L1: C21H16N2S9, Mr = 584.9, monoclinic, a =17.2349(4), b = 17.2808(4), 
c =  7.9477 (1)  Å, β = 92.095(15)o , V = 2365.50(8) Å3, Z = 4, space group P21/c, Dc = 
1.64 g cm-3, (Mo-K) = 0.86 mm-1, T = 120  K,  5429 unique reflections, 4408 with Fo 
> 4(Fo), final R1 = 0.044, wR2 = 0.099, crystals from DCM/hexane.    Crystal data have 
been deposited at the Cambridge Crystallographic Data Centre with deposition numbers 
968626-968627.   
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“Supporting Information Available: Listings of NMR and IR spectra for zinc complexes  
[(L2)3Zn](PF6)2, L2Zn(hfac)2 and [(L3)2Zn](PF6)2, tables of cyclic voltammetry data for 
ligands and complexes and room temperature magnetic moments for complexes, and u.v.-
visible spectra for [(L2)3Fe](PF6)2, and [(L3)2Fe](PF6)2 This material is available free of 
charge via the Internet at http://pubs.acs.org.” 
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BEDT-TTF functionalized with a 2,2’-bipyridin-4-thiomethyl side chain reacts with 
Fe(II) to form a capsule structure, characterized by X-ray crystallography, which is 
composed of two tris(ligand)Fe(II) complexes which are organized so that the ends of the 
sulfur donors from one complex lie in the clefts between bipy units on the second donor 
and vice-versa. Further coordination chemistry of this ligand and of the corresponding 4’-
terpy ligand with transition metal ions is reported. 
 
 
 
